The Impact of Alzheimer's Disease on the Chinese Economy

EBioMedicine. 2015 Dec 22:4:184-90. doi: 10.1016/j.ebiom.2015.12.019. eCollection 2016 Feb.

Abstract

Background: Recent increases in life expectancy may greatly expand future Alzheimer's Disease (AD) burdens. China's demographic profile, aging workforce and predicted increasing burden of AD-related care make its economy vulnerable to AD impacts. Previous economic estimates of AD predominantly focus on health system burdens and omit wider whole-economy effects, potentially underestimating the full economic benefit of effective treatment.

Methods: AD-related prevalence, morbidity and mortality for 2011-2050 were simulated and were, together with associated caregiver time and costs, imposed on a dynamic Computable General Equilibrium model of the Chinese economy. Both economic and non-economic outcomes were analyzed.

Findings: Simulated Chinese AD prevalence quadrupled during 2011-50 from 6-28 million. The cumulative discounted value of eliminating AD equates to China's 2012 GDP (US$8 trillion), and the annual predicted real value approaches US AD cost-of-illness (COI) estimates, exceeding US$1 trillion by 2050 (2011-prices). Lost labor contributes 62% of macroeconomic impacts. Only 10% derives from informal care, challenging previous COI-estimates of 56%.

Interpretation: Health and macroeconomic models predict an unfolding 2011-2050 Chinese AD epidemic with serious macroeconomic consequences. Significant investment in research and development (medical and non-medical) is warranted and international researchers and national authorities should therefore target development of effective AD treatment and prevention strategies.

Keywords: AD, Alzheimer's Disease; Alzheimer's Disease; CDR, Clinical Dementia Rating; CGE, Computable General Equilibrium; COI, Cost Of Illness; China; DALYs, Disability Adjusted Life Years; GDP, Gross Domestic Product; GTAP, Global Trade Analysis Project; IADL, Instrumental Activities of Daily Living; Macroeconomic; Modelling; NPV, Net Present Value; PADL, Personal Activities of Daily Living; RMB, Renminbi; SAM, Social Accounting Matrix; YLD, Years Lived with a Disability; YLL, Years of Life Lost; p.a., per annum.

MeSH terms

  • Alzheimer Disease / economics*
  • Alzheimer Disease / epidemiology
  • China
  • Cost of Illness
  • Gross Domestic Product
  • Health Care Costs*
  • Humans
  • Models, Economic*